Ourobionics - Crunchbase Company Profile & Funding

Overview

Ourobionics

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Ourobionics

CB Rank

1075921

Disruptive 4D biofabrication technology to merge human tissues with bioelectronics & biosensors for high throughput cyborganic applications

Founded

obfuscation

Private

Amsterdam, Noord-Holland, The Netherlands

1-10

www.ourobionics.com/home

Biotechnology

Key People

Prof. Suwan Jayasinghe: Co-Founder and CSO
Past Role: FluxBio Inc (Closed and became Frontier Bio Inc-Raised $3.5M), Co-founder and CSO
Doris Zoric: Co-Founder & CMO

Details

Legal Name

Ourobionics B.V.

Operating Status

Active

Company Type

For Profit

Founders

Alireza dolatshahi-pirouz, Doris Zoric, Elpiniki Tsekou, John Zandbergen, Patrick Yopp, Prof. Alvaro Mata, Prof. Suwan Jayasinghe, Stephen Gerard Gray

About the Company

Ourobionics BV: Disruptive, faster, nanoscale 4D biofabrication & tissue engineering technology proven to create complex human tissue with self-healing bioelectronics & disease biosensor readouts for ending animal testing in regenerative medicine. Individual technologies published to make complex healthy/diseased brain, lung, &

heart with 5 week survival.

Ourobionics are participants in the €450 million NxtGen HighTech national fund granted in 2022. Vision to create human-machine interfaces to diagnose, monitor, & regenerate diseases; therby transforming the $17 trillion longevity industry

Contact Email

info@ourobionics.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CHIMERA Biofabrication Platform

A 4D biofabrication system that deposits multiple biomaterials in gradients to create diverse 3D human tissue models with embedded biosensors and bioelectronics.

3D Bioprinter

A dual piston extrusion 3D bioprinter capable of printing viscous biomaterials with high precision and minimal cross-contamination, compatible with standard syringes and various containers.